This Plain Language Summary of Publication article (PLSP) from Pain Management presents findings from a clinical study evaluating rimegepant as a preventive migraine treatment. Researchers investigated whether an every-other-day dosing schedule of rimegepant could effectively reduce monthly migraine days for patients.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial’ and was published in The Lancet. 

Visit Elsevier using the link to read the original article.